ASCO Genitourinary Cancers Symposium 2026 February 26 - 28, 2026 San Francisco, California

Enfortumab Vedotin + Pembro Beats Cisplatin for Resectable MIBC M. Alexander Otto, PA, MMSc https://www.medscape.com/viewarticle/enfortumab-vedotin-pembro-beats-cisplatin-resectable-mibc-2026a10006gl?ecd=wnl_conf_onc_ASCO-GU-non-spon_260318_mscpedit_etid8194248&uac=148436CN&impID=8194248 March 02, 2026 ASCO Genitourinary Cancers Symposium 2026 February 26 - 28, 2026 San Francisco, California https://www.medscape.com/c25/p14/asco-genitourinary-cancers-symposium-2026-2026a100048v